The RNAi market achieved global sales of just over $1bn in 2004 and is projected to reach $2.5bn by 2010,a compound annual growth rate (CAGR)2004-2010 of 14%.‘The Outlook for RNAi: Accelerating drug discovery and the development of RNAi therapeutics’ analyzes the latest trends in the RNAi market, allowing pharmaceutical companies to decide which areas of RNAi technologies to invest in, to improve drug attrition rates and develop new therapeutic agents. RNAi therapeutics are forecast to generate sales of around $1bn by 2015 and this market has significant potential, should companies be able to overcome delivery constraints. This report analyzes future trends of RNAi and provides detailed insight into the most effective use of this novel technology in the drug discovery process .This report details recent alliances and acquisitions being made by big pharmaceutical companies, allowing you to assess their investment in this new and rapidly advancing field.
Published: May 2005 - Global. |
